Osamu Ogawa

3PUBLICATIONS
20CO-AUTHORS
Molecular targetsPredictive and prognostic markersHaematological tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (3)

|May 14, 2026
Dual inhibition of PARP and ATR induces synthetic lethal vulnerability in prostate cancer with CDK12 deficiency.

|Jul 27, 2023
Tumor immune microenvironment and clinical outcomes in stage IV urothelial cancer: YODO study.

Hiroyuki Nishiyama, Toyonori Tsuzuki, Chikara Ohyama

|Jul 18, 2022
Impact of germline HLA genotypes on clinical outcomes in patients with urothelial cancer treated with pembrolizumab.

Shuhei Takahashi, Shintaro Narita, Nobuhiro Fujiyama

Pageof 1

Frequent Collaborators

2 joint publications

Takashi Kobayashi

1 joint publications

Shuhei Takahashi

1 joint publications

Shintaro Narita

1 joint publications

Wataru Obara